New drug combo trial aims to fight advanced bowel cancer
NCT ID NCT05171660
Summary
This study is testing if adding a new immunotherapy drug called sintilimab to standard chemotherapy works better for people with advanced colorectal cancer that has spread and has a specific genetic change (RAS mutation). It will involve about 446 adults who have not yet received treatment for their advanced cancer. The goal is to see if the combination helps control the cancer for longer and improves survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER STAGE IV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xuefeng Fang
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.